41 results on '"GRIS, J.‐C."'
Search Results
2. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study
3. Obstetric antiphospholipid syndrome: early LMWH-induced variations of angiogenic factors predict placenta-mediated pregnancy complications: OR188
4. Obstetric antiphospholipid syndrome: early lmwh-induced variations of angiogenic factors predict pregnancy loss: OR190
5. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
6. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
7. Does the type of fluid affect rapidity of shock reversal in an anaesthetized-piglet model of near-fatal controlled haemorrhage? A randomized study
8. The hidden activism of the misnamed
9. Incidence of pregnancy outcomes in women with pregnancy loss subtypes bearing Leiden polymorphisms:comparison with the purely obstetric antiphospholipid syndrome: PB 4.66–3
10. Impact on the initial pregnancy loss subtype on pregnancy outcomes in the conventionally treated purely obstetric antiphospholipid syndrome: PB 4.65–1
11. Incidence of pregnancy outcomes in the conventionally treated purely obstetric antiphospholipid syndrome, pregnancy loss subtype: the NOH-APS observational study: PB 3.65–2
12. Circulating nucleosomes and plasma free DNA are increased in abnormal pregnancies: PB 2.66–2
13. Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal
14. Enoxaparin for the secondary prevention of placental vascular complications in women with previous severe pre-eclampsia: the pilot randomised controlled NOH-PE study: O-TH-095
15. Genetic variability of LXRbeta gene might contribute to preeclampsia: O-TH-094
16. Low molecular weight heparin for the secondary prevention of placental-mediated pregnancy complications: a systematic review and meta analysis: O-TH-091
17. Observational study of the various antiphospholipid antibodies-related deep venous thrombotic risk in women with an obstetrical antiphospholipid syndrome: O-WE-031
18. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay
19. Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels
20. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis
21. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies
22. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy
23. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
24. In PT G20210A carriers the genetic mutation and the history of venous thrombosis contribute both to thrombin generation independently of FII plasma levels: OC-WE-099
25. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages
26. Simple coagulation tests improve survival prediction in patients with septic shock
27. In support of the revised World Health Organization diagnostic criteria for essential thrombocythemia: JAK2 V617F and premature myocardial infarction
28. About the significance or the insignificance of the factor XII C46T polymorphism: reply to a rebuttal
29. Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation: a rebuttal
30. Simple coagulation tests improve early mortality prediction for patients in intensive care units who have proven or suspected septic shock
31. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy
32. Association of –592C/A, –819C/T and –1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion
33. Postpartum residual venous obstruction of the lower limbs in the matched case–control ‘NOHA first’ study on miscarriage
34. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control ‘NOHA First’ study
35. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case–control ‘NOHA first’ study
36. Diffuse skin necrosis in a patient with an anti-endothelial cell protein C receptor autoantibody which blocks protein C activation
37. High plasma levels of endothelial protein C receptor are associated with the risk of unexplained fetal death
38. The long and winding road … towards LMWH for pregnancy loss
39. Factor V Leiden, Prothrombin G20210A and antibodies against phospholipids in recurrent spontaneous abortion
40. ANTIPHOSPHOLIPID SYNDROME (APS): PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS.
41. Cutaneous thrombotic and necrotizing microangiopathy revealing a large granular lymphocytic leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.